Background Incremental cost-effectiveness and cost-utility analyses [health economic
evaluations (HEEs)] of vaccines are routinely considered in decision making on immunization in …

Recently, Covid-19 vaccine effectiveness has decreased especially against mild disease
due to emergence of the Delta variant and waning protection. In this register-based study …

Cost-effectiveness analyses are usually not directly comparable between countries
because of differences in analytical and modelling assumptions. We investigated the cost-…

Influenza vaccination of children 6–23 months of age is recommended in the United States
and Canada because of high rates of influenza-associated hospitalisations, but few other …

We evaluated the overall coverage, frequency and costs of Pap testing by screening modality
and health care provider in Finland. Information about Pap testing in the Finnish female …

INTRODUCTION: This study aimed to estimate the impact of rotavirus (RV) immunisation
programme on the total hospital treated acute gastroenteritis (AGE) burden, as well as, on …

The development of high-risk human papillomavirus (hrHPV) infection to cervical cancer is
a complicated process. We considered solely hrHPV infections, thus avoiding the …

Kansallisen rokotusohjelman estämistä tautitapauksista saadut säästöt hoitokustannuksissa
ylittävät rokotusohjelman kustannukset ainakin 60 miljoonalla eurolla. Rokotuksilla sekä …

Background In Finland, both mRNA and adenovirus vector (AdV) Covid-19 vaccines have
been used after the vaccination campaign started on December 27, 2020. Vaccination of the …

Background Vaccination is the most effective means of preventing the spread of infectious
diseases. Despite the proven benefits of vaccination, vaccine hesitancy keeps many people …